A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE TRIPLE COMBINATION OF AMLODIPINE/LOSARTAN/ROSUVASTATIN IN PATIENTS WITH ESSENTIAL HYPERTENSION

被引：0

作者：

Lee, H. ^{[1
]}

Park, S. ^{[2
]}

机构：

[1] Seoul Natl Univ Hosp, Seoul, South Korea

[2] Samsung Hosp, Seoul, South Korea

来源：

JOURNAL OF HYPERTENSION | 2017年 / 35卷

关键词：

D O I：

10.1097/01.hjh.0000523533.01598.7c

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

PP.12.23

引用

页码：E193 / E193

页数：1

共 50 条

[1] A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia
Lee, Hae-Young
Kim, Seok-Yeon
Choi, Kee-Joon
Yoo, Byung-Su
Cha, Dong-Hun
Jung, Hae Ok
Ryu, Dong-Ryeol
Choi, Joon Hyouk
Lee, Kwang Je
Park, Tae Ho
Oh, Ju Hyeon
Kim, Sang Min
Choi, Ji-Yong
Kim, Kye Hun
Shim, Jaemin
Kim, Woo-Shik
Choi, Si -Wan
Park, Dae-Gyun
Song, Pil-Sang
Hong, Taek-Jong
Rhee, Moo-Yong
Rha, Seung-Woon
Park, Seung Woo
CLINICAL THERAPEUTICS, 2017, 39 (12) : 2366 - 2379
[2] A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia
Min Chul Kim
Youngkeun Ahn
Moo Hyun Kim
Seok-Yeon Kim
Taek Jong Hong
Moo-Yong Rhee
Sang-Hyun Kim
Soon-Jun Hong
Hyungseop Kim
Weon Kim
In Ho Chae
Duk-hyun Kang
Byeong-Keuk Kim
Hyo-Soo Kim
American Journal of Cardiovascular Drugs, 2023, 23 : 441 - 454
[3] A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia
Kim, Min Chul
Ahn, Youngkeun
Kim, Moo Hyun
Kim, Seok-Yeon
Hong, Taek Jong
Rhee, Moo-Yong
Kim, Sang-Hyun
Hong, Soon-Jun
Kim, Hyungseop
Kim, Weon
Chae, In Ho
Kang, Duk-hyun
Kim, Byeong-Keuk
Kim, Hyo-Soo
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (4) : 441 - 454
[4] A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
Jeon, Eun-Seok
Lim, Sang Wook
Kim, Seok-Yeon
Yang, Hyoung-Mo
Kim, Moo Hyun
Rhee, Moo-Yong
Han, Seung Hwan
Shin, Jinho
Kim, Kwang-il
Jeong, Jin-Ok
Sung, Ki Chul
Hong, Geu Ru
Kim, Hyung-Seop
Kwon, Kihwan
Kang, Tae-Soo
Lee, Hae-Young
Han, Su-Eun
CLINICAL HYPERTENSION, 2022, 28 (01)
[5] A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
Eun-Seok Jeon
Sang Wook Lim
Seok-Yeon Kim
Hyoung-Mo Yang
Moo Hyun Kim
Moo-Yong Rhee
Seung Hwan Han
Jinho Shin
Kwang-il Kim
Jin-Ok Jeong
Ki Chul Sung
Geu Ru Hong
Hyung-Seop Kim
Kihwan Kwon
Tae-Soo Kang
Hae-Young Lee
Su-Eun Han
Clinical Hypertension, 28
[6] A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
Kim, Woohyeun
Chang, Kiyuk
Cho, Eun Joo
Ahn, Jeong-Cheon
Yu, Cheol Woong
Cho, Kyoung-Im
Kim, Yong-Jin
Kang, Duk-Hyun
Kim, Seok-Yeon
Lee, Sang-Hak
Kim, Ung
Kim, Shin-Jae
Ahn, Young Keun
Lee, Chang Hoon
Shin, Jin Ho
Kim, Mikyung
Park, Chang Gyu
JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (02): : 261 - 269
[7] Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study
Kim, Tae-Seok
Rha, Seung-Woon
Kim, Seok-Yeon
Park, Dae-Gyun
Sung, Ki-Chul
Yoon, Myung-Ho
Kim, Kye-Hoon
Lee, Han-Cheol
Kim, Woo-Sik
Kim, Yong-Jin
Ahn, Jeong-Cheon
Rhee, Moo-Yong
Cha, Dong-Hun
Yoo, Byung-Su
Park, Sang-Ho
Yoo, Ki-Dong
Jeon, Dong-Woon
Yoon, Young-Won
Cho, Sang-Kyoon
Oh, Yong-Seog
CLINICAL THERAPEUTICS, 2019, 41 (04) : 728 - 741
[8] A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy
Kim, Kwang-il
Shin, Mi-Seung
Ihm, Sang-Hyun
Youn, Ho-Joong
Sung, Ki-Chul
Chae, Shung Chull
Nam, Chang-Wool
Seo, Hong Seog
Park, Seong-Mi
Rhee, Moo-Yong
Kim, Moo Hyun
Cha, Kwang Soo
Kim, Yong-Jin
Kim, Jae-Joong
Chun, Kook Jin
Yoo, Byung-Su
Park, Sungha
Shin, Eun-Seok
Kim, Dong-Soo
Kim, Doo Il
Kim, Kye Hun
Joo, Seung-Jae
Jeong, Jin-Ok
Shin, Jinho
Kim, Cheol Ho
CLINICAL THERAPEUTICS, 2016, 38 (10) : 2159 - 2170
[9] Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
Zhang, Shuyang
Li, Ying
Xu, Xin
Xu, Rui
Zhang, Linchao
Wan, Xiaoqun
Yao, Zhuhua
Sun, Yuemin
Liu, Yong
Bin, Jianping
Wang, Zhen
Li, Shuren
Yang, Ping
Xu, Xiping
Liang, Weidong
Gao, Xiaohong
Li, Xiaodong
Jia, Min
Ma, Guang
Gu, Xiang
Hong, Chang
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[10] A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 x 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension
Lee, Hae-Young
Kim, Yong-Jin
Ahn, Taehoon
Youn, Ho-Joong
Chae, Shung Chull
Seo, Hong Seog
Kim, Ki-Sik
Rhee, Moo-Yong
Choi, Dong-Ju
Kim, Jae-Joong
Chun, Kook-Jin
Yoo, Byung-Su
Park, Jong-Seon
Oh, Seok-Kyu
Kim, Dong-Soo
Kwan, Jun
Ahn, Youngkeun
Park, Jeong Bae
Jeong, Jin-ok
Hyon, Min-Soo
Cho, Eun-Joo
Han, Kyoo-Rok
Kim, Doo-Il
Joo, Seung-Jae
Shin, Jin-Ho
Sung, Ki-Chul
Jeon, Eun-Seok
CLINICAL THERAPEUTICS, 2015, 37 (11) : 2581 - 2596

← 1 2 3 4 5 →